HK Stock MarketDetailed Quotes
02410 TYK MEDICINES-B
- 54.700
- +5.100+10.28%
Market Closed Dec 20 16:08 CST
20.28BMarket Cap-43.28P/E (TTM)
54.700High49.550Low201.55KVolume50.200Open49.600Pre Close10.31MTurnover0.11%Turnover RatioLossP/E (Static)370.84MShares54.70052wk High-17.69P/B10.53BFloat Cap12.86052wk Low--Dividend TTM192.59MShs Float54.700Historical High--Dividend LFY10.38%Amplitude12.860Historical Low51.164Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
TYK MEDICINES-B Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||
| Earning before tax | -26.28%-219.53M | -29.52%-107.78M | -22.89%-383.17M | -30.79%-266.18M | ---173.85M | ---83.21M | ---311.8M | ---203.52M |
| Profit adjustment | ||||||||
| Interest expense - adjustment | 20.64%3.67M | 23.77%1.79M | 194.63%6.37M | 241.12%4.69M | --3.04M | --1.44M | --2.16M | --1.37M |
| Investment loss (gain) | 84.56%-372K | 99.23%-12K | 43.44%-3.03M | 29.75%-2.95M | ---2.41M | ---1.57M | ---5.35M | ---4.2M |
| Revaluation surplus: | 22.59%47.2M | 21.72%23.44M | 14.17%78.52M | 16.58%58.09M | --38.5M | --19.26M | --68.77M | --49.83M |
| -Other fair value changes | 22.59%47.2M | 21.72%23.44M | 14.17%78.52M | 16.58%58.09M | --38.5M | --19.26M | --68.77M | --49.83M |
| Asset sale loss (gain): | ---- | ---- | -72.97%10K | -118.92%-7K | --3K | ---- | --37K | --37K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | -72.97%10K | -118.92%-7K | --3K | ---- | --37K | --37K |
| Depreciation and amortization: | 6.37%14.73M | 8.97%7.33M | 69.28%27.64M | 99.73%21.38M | --13.85M | --6.72M | --16.33M | --10.71M |
| -Amortization of intangible assets | -0.04%2.83M | -0.07%1.41M | -0.02%5.66M | 0.00%4.24M | --2.83M | --1.42M | --5.66M | --4.24M |
| Financial expense | 22.22%1.76M | -17.15%575K | 18.90%15.87M | -85.20%1.89M | --1.44M | --694K | --13.34M | --12.75M |
| Exchange Loss (gain) | 114.89%21K | ---- | ---7K | ---47K | ---141K | ---- | ---- | ---- |
| Special items | 656.67%16.15M | 763.95%9.12M | 407.30%5.81M | -281.31%-4.47M | ---2.9M | ---1.37M | ---1.89M | ---1.17M |
| Operating profit before the change of operating capital | -11.36%-136.38M | -12.94%-65.54M | -15.38%-251.99M | -39.80%-187.61M | ---122.47M | ---58.04M | ---218.4M | ---134.2M |
| Change of operating capital | ||||||||
| Accounts receivable (increase)decrease | 116.51%1.76M | 36.01%-6.85M | 42.49%-11.27M | 86.63%-6.56M | ---10.66M | ---10.7M | ---19.6M | ---49.09M |
| Accounts payable increase (decrease) | -105.59%-1.66M | -198.09%-11.53M | 1,374.38%62.32M | 765.41%37.63M | --29.69M | --11.75M | ---4.89M | --4.35M |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | --22.83M | ---- |
| Cash from business operations | -31.74%-136.28M | -47.26%-83.92M | 8.68%-200.94M | 12.51%-156.55M | ---103.44M | ---56.99M | ---220.05M | ---178.93M |
| Special items of business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --22.83M |
| Net cash from operations | -31.74%-136.28M | -47.26%-83.92M | 8.68%-200.94M | -0.28%-156.55M | ---103.44M | ---56.99M | ---220.05M | ---156.1M |
| Cash flow from investment activities | ||||||||
| Decrease in deposits (increase) | ---60M | ---60M | 120.03%1.17M | ---- | ---- | ---- | ---5.84M | ---- |
| Sale of fixed assets | --4.76M | --4.76M | 3,250.00%67K | --3K | ---- | ---- | --2K | ---- |
| Purchase of fixed assets | 63.55%-18.27M | 42.21%-18.07M | -29.53%-76.38M | -84.00%-67.96M | ---50.12M | ---31.26M | ---58.97M | ---36.93M |
| Purchase of intangible assets | ---- | ---- | 97.00%-876K | ---876K | ---876K | ---876K | ---29.21M | ---- |
| Recovery of cash from investments | -83.40%91.37M | -98.21%6.01M | -35.42%758.03M | -27.35%738.95M | --550.41M | --336.57M | --1.17B | --1.02B |
| Cash on investment | 70.95%-138M | 73.59%-75M | 50.81%-609M | 44.99%-604M | ---475M | ---284M | ---1.24B | ---1.1B |
| Net cash from investment operations | -592.16%-120.14M | -796.56%-142.29M | 146.16%73.01M | 156.16%66.12M | --24.41M | --20.43M | ---158.17M | ---117.73M |
| Net cash before financing | -224.44%-256.42M | -518.78%-226.21M | 66.17%-127.94M | 66.98%-90.42M | ---79.03M | ---36.56M | ---378.22M | ---273.83M |
| Cash flow from financing activities | ||||||||
| New borrowing | 42.15%92.4M | --80.4M | ---- | 62.50%65M | --65M | ---- | ---- | --40M |
| Issuing shares | --50M | --50M | -43.08%185M | -90.77%30M | ---- | ---- | --325M | --325M |
| Interest paid - financing | ---864K | ---73K | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---24.78M | ---24.7M | 22.23%-9.53M | ---- | ---- | ---- | ---12.25M | ---12.25M |
| Other items of the financing business | ---- | -80.95%10.96M | 26.40%48.52M | -3,698.24%-15.08M | ---- | --57.54M | --38.39M | ---397K |
| Net cash from financing operations | 125.06%114.65M | 102.62%116.59M | -36.21%224M | -77.32%79.92M | --50.94M | --57.54M | --351.14M | --352.35M |
| Effect of rate | -114.89%-21K | ---- | --7K | --47K | --141K | ---- | ---- | ---- |
| Net Cash | -404.65%-141.77M | -622.43%-109.62M | 454.74%96.06M | -113.38%-10.5M | ---28.09M | --20.98M | ---27.08M | --78.52M |
| Begining period cash | 105.85%186.83M | 105.85%186.83M | -22.98%90.76M | -22.98%90.76M | --90.76M | --90.76M | --117.84M | --117.84M |
| Cash at the end | -28.29%45.04M | -30.91%77.21M | 105.85%186.83M | -59.10%80.31M | --62.81M | --111.75M | --90.76M | --196.36M |
| Cash balance analysis | ||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
HK
Overall
Symbol
Price
% Chg
No Data
